Edition:
India

Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

25.23USD
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
$25.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
301,809
52-wk High
$28.66
52-wk Low
$1.94

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.00 -0.407
Mar '19 0.00 -0.322
FY 2018 Dec '18 0.00 -0.321
Sep '18 0.00 -0.315
Jun '18 0.00 -0.321
Mar '18 0.00 -0.188
FY 2017 Dec '17 0.00 -0.306
Sep '17 0.00 -0.272
Jun '17 0.00 -0.300
Mar '17 0.00 -0.409
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 6 0.00 0.00 0.00 --
Quarter Ending Dec-19 6 0.00 0.00 0.00 --
Year Ending Dec-19 6 0.00 0.00 0.00 15.00
Year Ending Dec-20 6 10.97 55.00 0.00 27.37
Earnings (per share)
Quarter Ending Sep-19 6 -0.39 -0.35 -0.43 -0.28
Quarter Ending Dec-19 6 -0.35 -0.30 -0.40 -0.28
Year Ending Dec-19 6 -1.46 -1.30 -1.54 -0.52
Year Ending Dec-20 6 -1.27 -0.85 -1.72 -0.90
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -38.95 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Axsome Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 29.17 24.71 99 --
13 Week 12.73 7.24 99 --
26 Week 67.57 54.83 99 --
52 Week -28.82 -39.67 62 --
YTD -8.15 -19.34 75 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.42%
# of Holders: 136
Total Shares Held: 18,387,536
3 Mo. Net Change: 3,430,331
# New Positions: 74
# Closed Positions: 12
# Increased Positions: 103
# Reduced Positions: 36
# Net Buyers: 67
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.